CASEY FISHER: Open Payments
NPI 1275780686 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,412 in 151 payments from 27 companies in 2025. Trend: 2023 $10,566 · 2024 $4,031 · 2025 $6,412
Food & beverage: $4,738Travel & lodging: $1,674
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 28 | $2,961 |
| Medtronic, Inc. | 19 | $772 |
| Globus Medical, Inc. | 27 | $668 |
| ABBVIE INC. | 15 | $476 |
| BIOTRONIK NRO, Inc. | 4 | $273 |
| Collegium Pharmaceutical, Inc. | 13 | $199 |
| Virtus Pharmaceuticals LLC | 5 | $128 |
| Ipsen Biopharmaceuticals, Inc | 4 | $121 |
| Forte Bio-Pharma LLC | 5 | $84 |
| Averitas Pharma Inc. | 2 | $82 |
Products named: Evoke, SYNCHROMEDII, Senza, Vyrsa V1, Prospera, QULIPTA, Belbuca, INTELLIS ADAPTIVESTIM.
Industry payments across CA — which companies pay providers there.
